PMC:7558914 / 13525-13728
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 69-76 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 69-76 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T7 | 116-123 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T8 | 116-123 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T9 | 172-179 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T10 | 172-179 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 330 | 69-76 | Chemical | denotes | heparin | MESH:D006493 |
| 331 | 116-123 | Chemical | denotes | heparin | MESH:D006493 |
| 332 | 172-179 | Chemical | denotes | heparin | MESH:D006493 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T93 | 0-203 | Sentence | denotes | All protocols included anticoagulant treatment (low-molecular-weight heparin as the first option and unfractionated heparin as an alternative) and recommended prophylactic heparin during hospitalization. |